Hbk Investments L P Abbott Laboratories Transaction History

Hbk Investments L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $673,662 - $814,242	-6,600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $284,479 - $346,904	-2,495 Reduced 27.43%	6,600 $781,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $8.32 Million - $10.2 Million	-72,053 Reduced 88.79%	9,095 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $667,695 - $727,596	6,359 Added 8.5%	81,148 $8.89 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $4.82 Million - $5.86 Million	52,611 Added 237.22%	74,789 $8.14 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $961,795 - $1.23 Million	-12,561 Reduced 36.16%	22,178 $2.03 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $179,473 - $199,796	2,286 Added 7.04%	34,739 $3.02 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.97 Million - $2.38 Million	32,453 New	32,453 $2.38 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.